Skip to main content

Clinic Cold Chain: Temperature Logs, Power Cuts and Stock Decisions

A clinic cold-chain log should connect each temperature observation to the equipment, monitoring device and products affected. Follow the exact product's storage requirements and the applicable programme procedure. When a reading is out of range or history is missing, separate affected stock, preserve the evidence and obtain an authorised disposition. A normal reading after power returns does not prove that the earlier stock remained suitable.

By Bractis · Updated · 15 min read

Indian clinics storing vaccines, insulin or other temperature-sensitive medicines and planning for power cuts, delivery delays and staff handovers.

Define what the fridge is allowed to hold

Start with a stock list that identifies the exact product, presentation, batch and storage state. An unopened insulin cartridge, an in-use pen and a vaccine vial may have different requirements even when staff call all of them 'fridge medicines'. The relevant label and service procedure should determine storage, rather than the equipment's display setting.

The 2018 MoHFW Immunization Handbook for Health Workers documents twice-daily temperature recording and equipment identification for programme cold-chain units. This is a dated programme example, not the latest complete operating protocol. Follow current local programme and product instructions. Two written observations are not a continuous history, and an old manual must not reduce the monitoring required for today's equipment.

Sanofi India's Lantus/Lantus SoloStar information, updated October 2025, separates unopened, room-temperature and in-use presentations in its storage table. A cartridge placed in a pen has different handling instructions from unopened refrigerated stock. This illustrates why exact product and state matter; it is not a storage rule for every insulin or permission to move an unfamiliar product between conditions.

Source: MoHFW/NHM: Immunization Handbook for Health Workers, 2018 — Table 5.7

Source: Sanofi India: Lantus and Lantus SoloStar product information, October 2025

Distinguish current temperature, minimum/maximum and missing data

A current reading answers what the monitoring device indicates now. A minimum/maximum record covers the interval since its reset. A continuous logger may provide timestamped observations between visits. Write which evidence exists so a later reviewer does not interpret two handwritten numbers as uninterrupted monitoring.

Record equipment and sensor identifiers, units, observation time and the person who checked. Preserve the raw logger export when investigating an event; a cropped screenshot of the latest number may omit the highest reading, a disconnected probe or an unsynchronised clock.

If a morning observation was missed, retain the gap. Copying the evening value into the morning box creates false evidence and makes the exposure window impossible to assess. Distinguish 'not checked', 'device unavailable' and 'data recovered from logger', because they require different follow-up.

Use a power-cut timeline without inventing the exposure duration

Consider a fictional clinic whose last documented in-range observation was at 08:00. Power failed at 10:20, an out-of-range reading was found at 11:05, and a documented return to range occurred at 12:15. The elapsed time from first observed excursion to return is 70 minutes. It is not proof that the entire excursion lasted exactly 70 minutes.

Without continuous data, the onset may have been before 11:05. The 08:00-to-12:15 evidence window spans four hours and fifteen minutes, but that is also not a measured duration outside range. Report both the observations and uncertainty; a manufacturer or programme adviser may need this distinction to assess specific batches.

Do not infer medicine temperature directly from the duration of the electricity failure. Equipment insulation, door opening, loading and sensor placement affect what happened. Likewise, reconnecting power or resetting an alarm is a maintenance action, not a decision to release held stock.

Separate immediate control from the final stock decision

CDC's vaccine guidance describes marking affected stock as not for use, maintaining appropriate conditions and seeking programme or manufacturer advice. It also warns that damage may not be visually apparent. This is US vaccine guidance; use the relevant Indian programme and product channels for the clinic's actual event, including the applicable disposition procedure.

The practical objective is to prevent accidental use while preserving enough information for a sound decision. A label on the fridge door is insufficient if affected boxes can move into an unmarked tray. Link the physical hold to product, batch, quantity and location, and tell the people who dispense or administer it.

Keep patient care moving through an authorised alternative supply or referral plan where needed. An inventory hold must not become an unexplained cancelled appointment. If stock may already have been used during the affected period, the clinician and responsible service should assess follow-through; staff should not send a generic reassurance message.

Source: CDC: Storage and Handling of Immunobiologics

Keep the evidence and decision in the same review

This original table helps a small clinic assemble a useful event record. It does not provide a stability calculator or permission to use a product after an excursion.

On a narrow screen, scroll the table horizontally to read all columns.

Cold-chain evidence and the questions it can answer
EvidenceUseful interpretationLimit
Current readingIndicated temperature at the recorded timeDoes not recover the overnight history
Min/max readingsExtremes since a documented resetMay not show when or how long they occurred
Logger exportTimestamped measurements and gapsClock, probe placement and device status still matter
Power and door eventsContext for investigating an excursionNot a substitute for temperature evidence
Batch inventory and movementsWhich stock may have been exposed or usedA fridge-level total cannot identify every affected batch
Manufacturer/programme adviceProduct-specific disposition and conditionsApplies only to the described evidence and scope
Return-to-service checkEquipment can resume its agreed roleDoes not automatically release previously held stock

Worked example: the min/max display does not supply a time history

Fictional clinic event CC-24 in Nagpur occurs on 29 October 2026. The relevant monitoring procedure has already defined the applicable limits for the products under review. The staff record contains an 08:00 observation, a reported 10:20 power failure, an 11:05 out-of-range observation and a 12:15 return-to-range observation. Keep the earlier example's two intervals: 70 minutes between the latter observations, and 4 hours 15 minutes from the last documented in-range observation to the later one. Neither is a measured continuous excursion duration.

The min/max display adds another piece of evidence. At 11:05 it shows a minimum of 1.6°C and a maximum of 10.4°C; its last documented reset was at 17:30 on 28 October. That covers a 17-hour-35-minute reporting window. It does not reveal the time, order or duration of those extremes. The team must not allocate the minimum to the night and the maximum to the power cut merely because that story seems plausible.

Preserve the readings and the documented reset before clearing the display, following the device's procedure. Record which probe and unit produced them and whether a timestamped export is available. If a logger file later supplies additional observations, attach the original file and explain how its clock relates to clinic time. Do not turn an analyst's reconstructed sequence into the original device record.

The actual temperature of every vial or cartridge has not been measured by these observations. Probe position, device reliability and the stock's movement still matter to the responsible assessment. A single current 6.1°C reading at 13:00 does not erase the earlier evidence. A photograph of that reassuring display, separated from the min/max and reset information, would be an incomplete account to send for advice.

On a narrow screen, scroll the table horizontally to read all columns.

CC-24: four evidence sources with different time coverage
EvidenceRecorded factsWhat it establishesWhat remains unknown
Manual observations29 October: 08:00, 11:05 and 12:15Observations separated by 255 minutes overall; 70 minutes from 11:05 to 12:15Onset, continuity and full duration outside the applicable limits
Min/max displayRead at 11:05 on 29 October; reset at 17:30 on 28 OctoberMinimum 1.6°C and maximum 10.4°C within a 17-hour-35-minute windowWhen, for how long and in what order the extremes occurred
Power eventFailure reported at 10:20 on 29 OctoberAn equipment-context eventThe product temperature or exact excursion onset
Later current reading6.1°C at 13:00 on 29 OctoberIndicated temperature at that observationSuitability of previously held stock or the earlier history

Reconcile batch movements before applying a release decision

CC-24 begins with 24 vaccine vials of batch V-A, 10 vaccine vials of V-B and eight unopened insulin cartridges I-C. These are fictional products and counting units. They are not assumed to share a stability limit, storage policy or number of doses per container. The vaccine vial total is 34; the eight cartridges remain a separate quantity rather than becoming '42 vaccine doses'.

Six V-A vials were transferred at 09:30 to an alternate site, leaving 18 in the original location. One V-B vial is recorded as used at 10:40, leaving nine physically present. At the initial reconciliation, 33 vaccine vials are accounted for under hold across the locations, one vial has a documented-use record, and eight cartridges are held separately. The inventory count alone does not identify how many people received vaccine; the actual administration records must be traced for clinical review.

The six transferred vials need their own transport and receiving history. Leaving the original fridge before the reported power failure does not by itself prove an acceptable earlier history or transfer. Conversely, they should not be assigned the original fridge's later readings as though they remained there. Describe the evidence available for each location and ask the reviewer to identify the precise stock covered by their advice.

To test a scoped decision, the exercise supplies a hypothetical authorised release covering only the 18 V-A vials that remained in the original location. This is an assumed administrative outcome, not a stability conclusion drawn from the temperatures above. No real product-release rule can be inferred. After staff implement that particular decision, the vaccine ledger shows 18 available, 15 still held and one previously used, accounting for all 34 original vials. The eight I-C cartridges remain held under their separate review.

A reply saying 'batch V-A acceptable' is insufficient if the evidence submitted described only one location. Clarify the scope before applying it to the other six. Keep the reviewer, reference, conditions and implementation time with the decision. A stock screen should not remove every hold merely because the batch name matches or because a technician has returned the fridge to service.

On a narrow screen, scroll the table horizontally to read all columns.

CC-24: quantities after the hypothetical scoped release is implemented
Stock groupOpening quantityAccounted statusOutstanding evidence or action
V-A vaccine batch24 vials18 available at the original site; 6 held at the alternate siteSeparate transport/receiving history and disposition for the six
V-B vaccine batch10 vials9 held; 1 vial recorded as used before the holdBatch disposition and clinical review of the actual administration records
I-C insulin batch8 cartridges8 held; none released in this exerciseProduct- and state-specific assessment; do not count cartridges as vaccine doses

Source: CDC: Storage and Handling of Immunobiologics

Close the equipment job without losing the remaining stock work

The filled handover should let an evening team answer three different questions: is the equipment ready for its approved use, which physical stock is available, and what clinical follow-through remains? A repair invoice answers none of these by itself. The equipment owner needs the required recovery verification; the stock owner needs the relevant disposition evidence; the treating team needs any administration information requiring assessment.

Use location-specific labels and movements that staff can actually follow. If the released 18 vials remain in a hold tray, record that implementation is pending rather than advertising them as available. If the six alternate-site vials return later, receipt must preserve their unresolved hold. Do not let the transfer transaction overwrite the decision state. The inventory screen and the physical arrangement should agree before the next session draws stock.

Continue patient care through a properly authorised alternative arrangement where needed. A receptionist should have a clear service plan to explain, rather than guessing whether an appointment must be cancelled or reassuring a patient about an exposure that has not been assessed. Retain the actual contact and clinical advice separately from the inventory investigation. No patient message or real product disposition is performed in this teaching case.

Review the cause only after immediate care and stock controls are in place. A missing reset entry, unavailable alternate-site contact and unclear batch-location record are different problems requiring different fixes. Rehearse those specific failures with demonstration stock and the actual staff roles. Completing a fridge repair or a practice drill does not show that the clinic's future cold-chain performance is guaranteed.

Test the backup location before the monsoon outage

Name a primary coordinator and an alternate who can act when the clinic owner is consulting or away. Keep access arrangements, service contacts and the approved transfer procedure available without depending on the failed device or an internet connection.

Identify a suitable alternate storage site and how it will confirm capacity, temperature conditions and receipt. A neighbouring clinic's verbal promise is incomplete if nobody can open it after hours. Transport requires its own product-appropriate protection and monitoring; improvised direct contact with ice can introduce another exposure problem.

A rehearsal can use empty demonstration boxes and fictional inventory. Walk through who receives an alarm, who authorises movement, who records departure and arrival and how stock remains held. Record the unresolved obstacle, such as an unreachable alternate or missing transport equipment, and assign an owner.

Use separate equipment and stock closure fields

A maintenance technician may restore the refrigerator before the stock assessment is finished. Keep those decisions separate. A service invoice establishes work performed, whereas a release record should identify which batches were approved, on whose advice and under what conditions.

For a local software evaluation, use two fictional batches with different outcomes. The system should preserve the event evidence and hold the unresolved batch even after the equipment status returns to active. This is an evaluation scenario, not a claim that Bractis has validated stability decision support.

Fictional example: power returns before the stock is released

A clinic's refrigerator recovers after an outage. Two batches were present, and one was partly transferred earlier in the morning. Staff retain the movement records and mark both as under review. Product-specific advice later permits one batch to return to available stock; the other remains held pending missing transport information. The fridge can be operational while part of its stock is unavailable, and the record makes that distinction visible.

Cold-Chain Event and Stock Worksheet

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Product requirements
Which exact product and storage state does each instruction cover?
Evidence gaps
What does the monitoring history establish, and what duration remains unknown?
Affected inventory
Can you identify batches, quantities and movements during the event?
Separate closure
Who authorises equipment recovery and who authorises each stock disposition?

Questions doctors ask

Do two normal fridge readings prove there was no temperature excursion?

No. They describe the recorded observation times. Review the available minimum/maximum or logger history and preserve any gaps rather than assuming continuous compliance.

Can held stock be used as soon as the fridge is back in range?

Equipment recovery and stock suitability are different decisions. Obtain and retain the appropriate product-specific or programme advice before releasing affected stock.

Can vaccines and all insulin presentations use one storage rule?

Do not assume that. Verify the exact product, presentation and unopened or in-use state, along with the applicable service procedure.

Should every vaccine temperature excursion lead to immediate disposal?

Separate affected stock from use and obtain the responsible programme or manufacturer assessment. The evidence, product and exposure determine disposition; a generic automatic disposal rule loses that distinction.

Is the length of the power cut the exposure duration?

Not necessarily. It is contextual evidence. Use actual temperature observations and identify uncertainty rather than treating electrical outage time as measured product exposure.

Can minimum and maximum fridge temperatures tell us how long stock was outside range?

Not by themselves. They identify extremes within the interval since the documented reset, not their timestamps or duration. Preserve the reset, readings, device context and any logger data for the appropriate product-specific assessment.

Does a release decision for one batch automatically cover stock moved to another site?

No. Check which quantities, locations and exposure histories the advice actually covers. Transferred stock may need separate transport and receiving evidence; the same batch number does not make those histories identical.

Sources and scope

Updated on . This article combines the cited references with Bractis’s original workflow analysis and illustrative examples. Product capabilities depend on the configured scope. No independent clinical or legal review is claimed.

Try the workflow
with Bractis.

Run a fictional power-cut event with two batches, a missing observation and different disposition decisions; verify that equipment recovery does not silently release unresolved stock.

Request a clinic demo